Latest Lilly Stories
Alliance Marks One of the Largest Biotech Drug Development Collaborations in China BEIJING, March 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Innovent Biologics, Inc.
Development planned for multiple autoimmune diseases, including rheumatoid arthritis and lupus INDIANAPOLIS, March 19, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Hanmi
Alimta Compound Patent to Provide Exclusivity in Germany Through December 2015 INDIANAPOLIS, March 6, 2015 /PRNewswire/ -- The German Court of Appeal has ruled that Eli Lilly and Company's
- Between March 5 and May 31, 2015, for every purchase of K9 Advantix® II flea and tick preventive, Bayer will donate $1 per package to K9s for Warriors -- up to $150,000 SHAWNEE, Kan.
- Potentially first biomarker-guided schizophrenia therapeutic SAN DIEGO, March 3, 2015 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has exclusively licensed
INDIANAPOLIS, Feb. 24, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present at the 35(th) Annual Cowen and Company Health Care Conference on Tuesday, March 3, 2015. Mr.
INDIANAPOLIS, Feb. 6, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will present at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11, 2015.
Only prescription medication in U.S. to combine the dual mechanisms of action of SGLT2 and DPP-4 inhibitors to improve glycemic control as an adjunct to diet and exercise RIDGEFIELD, Conn.
INDIANAPOLIS, Jan. 30, 2015 /PRNewswire/ -- -- Fourth-quarter 2014 revenue declined 12 percent driven by the impact of U.S.
- The parings of haberdine; also, any kind of fragments.